Investors / OphthaFund
OphthaFund
Venture capital
OphthaFund is an investment fund focused primarily on technologies addressing eye disease and eye care. It invests across stages and technologies, including therapeutics, medical devices, diagnostics and imaging, surgical technologies, drug delivery, digital solutions, and clinical research tools and platforms.
Invests inHealthcare & Biotech
In its own wordsophthalmologyeye caremedical devicesbiotechnologydiagnosticsdrug delivery
Your fit with OphthaFund
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsOphthaFund lists 3 checked portfolio companies on its own site. Its largest theme is Healthcare & Biotech (100%). 100% of its companies are based in Germany. It invests most often alongside A-Level Capital, Catalio Capital Management and EcoR1 Capital.
No funding round on record names OphthaFund yet, so the figures come from its portfolio page.
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| A-Level Capital | 1 |
| Catalio Capital Management | 1 |
| EcoR1 Capital | 1 |
| Evolution VC Partners | 1 |
| ExSight Ventures | 1 |
| Plum Alley Ventures | 1 |
| Socii Capital | 1 |
| Tribe Capital | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers3100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherCompare OphthaFund head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Portfolio
3 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Ashvattha Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel precision nanomedicines to treat unmet medical needs in ophthalmology, neurology, and inflammatory diseases. | Healthcare & Biotech | Portfolio page | ||
| Elios Vision distributes and manufactures products for glaucoma treatment. | Healthcare & Biotech | Portfolio page | ||
| MCAL Therapeutics develops therapeutic solutions for the treatment of evaporative dry eye disease | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- ophthafund.com
- Last read
- 5 Nov 2026
- Watching since
- 7 Nov 2026
- Companies checked
- 3
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get OphthaFund's profile as data
Pull OphthaFund's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/ophthafund.com
# also
GET /v1/firms/ophthafund.com/portfolio
GET /v1/firms/ophthafund.com/coinvestors
GET /v1/firms/ophthafund.com/news